Skip to main content
Top
Published in: World Journal of Surgical Oncology 1/2014

Open Access 01-12-2014 | Case report

A case report of retroperitoneal pararenal Castleman’s disease associated with myasthenia gravis

Authors: Shuai Wang, Shan-Wen Chen, Song-Liang Cai, Bai-Yan Jin

Published in: World Journal of Surgical Oncology | Issue 1/2014

Login to get access

Abstract

Background

Castleman’s disease (CD) is a relatively rare disorder characterized by the benign proliferation of lymphoid tissue. The combination of an occurrence of retroperitoneal pararenal CD with myasthenia gravis (MG) is extremely rare.

Case presentation

The patient was admitted to our hospital for investigation of a retroperitoneal pararenal tumor which had been coincidentally diagnosed at a local hospital where he was admitted because of MG. The patient subsequently underwent an exploratory laparotomy and suffered from postoperative myasthenic crisis. Pathological examination revealed a left retroperitoneal mass of CD (hyaline vascular type). There was no recurrence of disease found after 7 months.

Conclusions

CD with MG is a rare condition. Postoperative myasthenic crisis is a severe complication. The possibility of its occurrence must be in physicians’ minds and the risk of postoperative myasthenic crisis must be carefully considered when evaluating MG patients undergoing surgery.
Appendix
Available only for authorised users
Literature
1.
go back to reference Castleman B, Iverson L, Menendez VP: Localized mediastinal lymph node hyperplasia resembling thymoma. Cancer. 1956, 9: 822-830. 10.1002/1097-0142(195607/08)9:4<822::AID-CNCR2820090430>3.0.CO;2-4.CrossRefPubMed Castleman B, Iverson L, Menendez VP: Localized mediastinal lymph node hyperplasia resembling thymoma. Cancer. 1956, 9: 822-830. 10.1002/1097-0142(195607/08)9:4<822::AID-CNCR2820090430>3.0.CO;2-4.CrossRefPubMed
2.
go back to reference Okada S, Maeta H, Maeba T, Goda F, Mori S: Castleman disease of the pararenal retroperitoneum: report of a case. Surg Today. 1999, 29: 178-181. 10.1007/BF02482246.CrossRefPubMed Okada S, Maeta H, Maeba T, Goda F, Mori S: Castleman disease of the pararenal retroperitoneum: report of a case. Surg Today. 1999, 29: 178-181. 10.1007/BF02482246.CrossRefPubMed
3.
go back to reference Emson HE: Extrathoracic angiofollicular lymphoid hyperplasia with coincidental myasthenia gravis. Cancer. 1973, 31: 241-245. 10.1002/1097-0142(197301)31:1<241::AID-CNCR2820310132>3.0.CO;2-T.CrossRefPubMed Emson HE: Extrathoracic angiofollicular lymphoid hyperplasia with coincidental myasthenia gravis. Cancer. 1973, 31: 241-245. 10.1002/1097-0142(197301)31:1<241::AID-CNCR2820310132>3.0.CO;2-T.CrossRefPubMed
4.
go back to reference Pasaoglu I, Dogan R, Topcu M, Gungen Y: Multicentric angiofollicular lymph-node hyperplasia associated with myasthenia gravis. Thorac Cardiovasc Surg. 1994, 42: 253-256. 10.1055/s-2007-1016500.CrossRefPubMed Pasaoglu I, Dogan R, Topcu M, Gungen Y: Multicentric angiofollicular lymph-node hyperplasia associated with myasthenia gravis. Thorac Cardiovasc Surg. 1994, 42: 253-256. 10.1055/s-2007-1016500.CrossRefPubMed
5.
go back to reference Chorzelski T, Hashimoto T, Maciejewska B, Amagai M, Anhalt GJ, Jablonska S: Paraneoplastic pemphigus associated with Castleman tumor, myasthenia gravis and bronchiolitis obliterans. J Am Acad Dermatol. 1999, 41 (3 Pt 1): 393-400.CrossRefPubMed Chorzelski T, Hashimoto T, Maciejewska B, Amagai M, Anhalt GJ, Jablonska S: Paraneoplastic pemphigus associated with Castleman tumor, myasthenia gravis and bronchiolitis obliterans. J Am Acad Dermatol. 1999, 41 (3 Pt 1): 393-400.CrossRefPubMed
6.
go back to reference Day JR, Bew D, Ali M, Dina R, Smith PL: Castleman’s disease associated with myasthenia gravis. Ann Thorac Surg. 2003, 75: 1648-1650. 10.1016/S0003-4975(02)04963-9.CrossRefPubMed Day JR, Bew D, Ali M, Dina R, Smith PL: Castleman’s disease associated with myasthenia gravis. Ann Thorac Surg. 2003, 75: 1648-1650. 10.1016/S0003-4975(02)04963-9.CrossRefPubMed
7.
go back to reference Ishikawa K, Kato T, Aragaki M, Ohbuchi T, Kimura S, Matsui Y, Kaji M: A case of Castleman’s disease with myasthenia gravis. Ann Thorac Cardiovasc Surg. 2013, [Ahead of print] Ishikawa K, Kato T, Aragaki M, Ohbuchi T, Kimura S, Matsui Y, Kaji M: A case of Castleman’s disease with myasthenia gravis. Ann Thorac Cardiovasc Surg. 2013, [Ahead of print]
8.
go back to reference Dispenzieri A, Gertz MA: Treatment of Castleman's disease. Curr Treat Options Oncol. 2005, 6: 255-266. 10.1007/s11864-005-0008-z.CrossRefPubMed Dispenzieri A, Gertz MA: Treatment of Castleman's disease. Curr Treat Options Oncol. 2005, 6: 255-266. 10.1007/s11864-005-0008-z.CrossRefPubMed
9.
go back to reference Klein WM, Rencic A, Munshi NC, Nousari CH: Multicentric plasma cell variant of Castleman’s disease with cutaneors involvement. J Cutan Pathol. 2004, 31: 448-452. 10.1111/j.0303-6987.2004.00117.x.CrossRefPubMed Klein WM, Rencic A, Munshi NC, Nousari CH: Multicentric plasma cell variant of Castleman’s disease with cutaneors involvement. J Cutan Pathol. 2004, 31: 448-452. 10.1111/j.0303-6987.2004.00117.x.CrossRefPubMed
10.
go back to reference Nishimoto N, Sasai M, Shima Y, Masashi N, Matsumoto T, Shirai T, Kishimoto T, Yoshizaki K: Improvement in Castleman’s disease by humanized anti-interleukin-6 receptor antibody therapy. Blood. 2000, 95: 56-61.PubMed Nishimoto N, Sasai M, Shima Y, Masashi N, Matsumoto T, Shirai T, Kishimoto T, Yoshizaki K: Improvement in Castleman’s disease by humanized anti-interleukin-6 receptor antibody therapy. Blood. 2000, 95: 56-61.PubMed
11.
go back to reference Yoshizaki K, Matsuda T, Nishimoto N, Kuritani T, Taeho L, Aozasa K, Nakahata T, Kawai H, Tagoh H, Komori T: Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman’s disease. Blood. 1989, 74: 1360-1367.PubMed Yoshizaki K, Matsuda T, Nishimoto N, Kuritani T, Taeho L, Aozasa K, Nakahata T, Kawai H, Tagoh H, Komori T: Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman’s disease. Blood. 1989, 74: 1360-1367.PubMed
12.
go back to reference Takatsu K: Cytokines involved in B-cell differentiation and their sites of action. Proc Soc Exp Biol Med. 1997, 215: 121-133. 10.3181/00379727-215-44119.CrossRefPubMed Takatsu K: Cytokines involved in B-cell differentiation and their sites of action. Proc Soc Exp Biol Med. 1997, 215: 121-133. 10.3181/00379727-215-44119.CrossRefPubMed
13.
14.
go back to reference Oosterhuis HJGH: Myasthenia Gravis. 1984, Edinburgh: Churchill Livingstone, 2011-2015. Oosterhuis HJGH: Myasthenia Gravis. 1984, Edinburgh: Churchill Livingstone, 2011-2015.
15.
go back to reference Berrouschot J, Baumann I, Kalischewski P, Strker M, Schneider D: Therapy of myasthenic crisis. Crit Care Med. 1997, 25: 1228-1235. 10.1097/00003246-199707000-00027.CrossRefPubMed Berrouschot J, Baumann I, Kalischewski P, Strker M, Schneider D: Therapy of myasthenic crisis. Crit Care Med. 1997, 25: 1228-1235. 10.1097/00003246-199707000-00027.CrossRefPubMed
16.
go back to reference Thomas CE, Mayer SA, Gungor Y, Swarup R, Webster EA, Chang I, Brannagan TH, Fink ME, Rowland LP: Myasthenic crisis: clinical features, mortality, complications, and risk factors for prolonged intubation. Neurology. 1997, 48: 1253-1260. 10.1212/WNL.48.5.1253.CrossRefPubMed Thomas CE, Mayer SA, Gungor Y, Swarup R, Webster EA, Chang I, Brannagan TH, Fink ME, Rowland LP: Myasthenic crisis: clinical features, mortality, complications, and risk factors for prolonged intubation. Neurology. 1997, 48: 1253-1260. 10.1212/WNL.48.5.1253.CrossRefPubMed
Metadata
Title
A case report of retroperitoneal pararenal Castleman’s disease associated with myasthenia gravis
Authors
Shuai Wang
Shan-Wen Chen
Song-Liang Cai
Bai-Yan Jin
Publication date
01-12-2014
Publisher
BioMed Central
Published in
World Journal of Surgical Oncology / Issue 1/2014
Electronic ISSN: 1477-7819
DOI
https://doi.org/10.1186/1477-7819-12-331

Other articles of this Issue 1/2014

World Journal of Surgical Oncology 1/2014 Go to the issue